http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1806416-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0bd2564785dbfbd379992a7ee616c6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2004-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96df7fde68bea2ca2c5d6d49f028151c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9a56de9320dc543fd2c73c5cc204a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85bccbe4ab7ee3eea25c3b5b56e383df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fbb63a0ab57064b2f72b98f6d2f06e7
publicationDate 2007-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1806416-A2
titleOfInvention Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia
abstract The invention relates to a real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) method for minimal residual disease detection in leukemic patients through amplification of a fusion gene transcript BCR-ABL, comprising: n(i) selecting amplifiable and qualified patient samples for subsequent analysis; n(ii) defining optimal conditions for performing the RT reaction; n(iii) defining optimal conditions for RQ-PCR protocol; and n(iv) establishing a standardized procedure for data analysis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2638800-C2
priorityDate 2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10209071-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127591552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129068198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12310447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129195613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127384203

Total number of triples: 43.